LTGO
Latigo Biotherapeutics Inc.
There isn't enough reported data to score LTGO yet.
LTGO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate LTGO's fundamentals.
LTGO PE Valuation
LTGO has no meaningful PE right now: it lost money over the past year.
LTGO Forward outlook
There aren't enough analyst estimates for LTGO to show an outlook.
LTGO Earnings Per Share
LTGO Quarterly Revenue
LTGO Free Cash Flow
LTGO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3947% | +36.9M shares |
LTGO Net Leverage
LTGO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LTGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
As of the close on Nov 12, 2026: $12.93.
LTGO PE vs Healthcare Sector
LTGO has no meaningful PE right now: it lost money over the past year.
LTGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 12% below |
LTGO is in a downtrend: it's below all one of its weekly moving averages, and 12% below its 8-week average.
LTGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $18.3 | $12.9 | -29% |
It's down 29% so far in 2026.